Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I-IIa study of allogeneic expanded adipose-derived stem cells for complex perianal fistulas in Crohn's disease
2008-007445-31Phase 2Completed
- Sponsor
- Cellerix S.A.
- Start
- Jan 2009
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of darvadstrocel in Crohn's disease and anal fistula, sponsored by Cellerix S.A. Primary endpoint: Incidence of treatment-emergent adverse events. Started Jan 2009; status: completed.
02
Drugs
darvadstrocel
03
Conditions
Crohn's diseaseanal fistula
Beyond the preview
Go deeper on 2008-007445-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007445-31.